Skip to main content
Cisen Pharmaceutical Co.,Ltd. logo

Cisen Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 603367 ISIN · CNE100002VG4 LEI · 836800T7RRJXURVHYS35 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,110 across all filing types
Latest filing 2024-02-28 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603367

About Cisen Pharmaceutical Co.,Ltd.

https://www.cisen-pharma.com/

Cisen Pharmaceutical Co.,Ltd. is a comprehensive enterprise dedicated to the research, development, production, and marketing of a diverse range of medicinal products. The company specializes in the manufacture of large-volume injections, small-volume injections, and solid oral dosage forms, including tablets and capsules. Its product portfolio addresses critical therapeutic areas such as parenteral nutrition, anti-infectives, cardiovascular health, and anesthesia. Cisen Pharmaceutical maintains an integrated value chain, producing both active pharmaceutical ingredients (APIs) and finished formulations. The organization emphasizes technological innovation and stringent quality management systems to ensure the efficacy and safety of its medical solutions. By leveraging advanced manufacturing capabilities and a robust distribution network, the company provides essential healthcare products to clinical institutions and medical providers.

Recent filings

Filing Released Lang Actions
辰欣药业股份有限公司第五届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the first meeting of the fifth board of directors of the company. It details the election and appointment of the chairman, board committees, general manager, financial director, deputy general managers, chief engineer, board secretary, and securities affairs representative. The content focuses on changes and appointments in the company's board and senior management. There are no financial statements, earnings data, or regulatory filings related to financial performance. The document is not a report but an announcement of board and management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and specific to management appointments, confirming this classification with high confidence.
2024-02-28 Chinese
北京市盈科（济南）律师事务所关于辰欣药业股份有限公司2024年第一次临时股东大会的法律意见书
Regulatory Filings
2024-02-28 Chinese
辰欣药业股份有限公司2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 first extraordinary general meeting of shareholders of the company. It includes information about the meeting date, location, attendance, voting results for board and supervisory board elections, and legal witness statements. The content focuses on the voting outcomes and official confirmation of the shareholder meeting decisions. There is no financial data, earnings information, or report publication mentioned. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 2400 characters, which is consistent with a detailed voting results announcement rather than a full report or a brief notice. Therefore, the correct classification is DVA with high confidence.
2024-02-28 Chinese
辰欣药业股份有限公司第五届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first meeting of the fifth Supervisory Board of the company, including the election of the Supervisory Board Chairman. It details the meeting date, attendance, voting results, and includes a brief biography of the elected chairman. There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory filings or certifications. The content is about board/management changes specifically related to the Supervisory Board leadership. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a report or announcement of a report publication.
2024-02-28 Chinese
辰欣药业股份有限公司关于使用闲置的募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the progress of using idle raised funds for cash management, specifically investing in bank wealth management products. It includes information about the board meeting approval, investment amounts, product details, risk control measures, and financial impact. The document is not a full financial report but an update on capital management activities related to fundraising proceeds. It does not contain comprehensive financial statements or quarterly/yearly financial results. The content fits the description of a Capital/Financing Update (CAP) as it provides updates on the company's use of raised funds for cash management and investment activities.
2024-02-28 Chinese
辰欣药业股份有限公司关于董事会、监事会完成换届选举暨聘任高级管理人员、证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about the completion of the board of directors and supervisory board re-election, as well as the appointment of senior management and securities affairs representatives. It details the composition of the new board, committees, and management personnel, including their resumes. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's board and senior management personnel. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed information about the board and management changes, confirming the classification.
2024-02-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.